Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Influenza Virus Vaccine”

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT04471038
What this trial is testing

Safety, Tolerability, and Pharmacokinetics of SAB-176 in Healthy Participants

Who this might be right for
Influenza Type AInfluenza Type BInfluenza
SAb Biotherapeutics, Inc. 27
Post-approval studies (Phase 4)Study completedNCT03735147
What this trial is testing

Assessment of Viral Shedding Week Following Administration of Live Attenuated Influenza Vaccine in Children

Who this might be right for
Influenza Vaccines
Imperial College London 12
Early research (Phase 1)Study completedNCT02708173
What this trial is testing

Safety Study of Quadrivalent Influenza Virus Vaccine in Healthy People Aged 3 Years and Older

Who this might be right for
Quadrivalent Influenza Virus Vaccine
Beijing Chaoyang District Centre for Disease Control and Prevention 40
Post-approval studies (Phase 4)Study completedNCT02225327
What this trial is testing

MF59-adjuvanted Influenza Vaccine and 23-valent Pneumococcal Polysaccharide Vaccine

Who this might be right for
Influenza, HumanPneumococcal Infections
Korea University Guro Hospital 224
Testing effectiveness (Phase 2)WithdrawnNCT01008956
What this trial is testing

Safety and Immune Response of One-Dose of Candidate H1N1 Influenza Vaccine GSK2340274A in Adults

Who this might be right for
Influenza
GlaxoSmithKline
Not applicableStudy completedNCT01207557
What this trial is testing

Controlled Trial of the Effectiveness of the Ottawa Influenza Decision Aid

Who this might be right for
Influenza
Ottawa Hospital Research Institute 300
Large-scale testing (Phase 3)Study completedNCT04841577
What this trial is testing

A Study on the Immune Response and Safety Elicited by a Vaccine Against Respiratory Syncytial Virus (RSV) When Given Alone and Together With a Vaccine Against Influenza in Adults Aged 60 Years and Above

Who this might be right for
Respiratory Syncytial Virus Infections
GlaxoSmithKline 976
Large-scale testing (Phase 3)Study completedNCT04120194
What this trial is testing

Phase 3 Pivotal Trial of NanoFlu™ in Older Adults

Who this might be right for
Influenza, Human
Novavax 2,654
Testing effectiveness (Phase 2)Looking for participantsNCT07431853
What this trial is testing

Learn About mRNA Vaccines Against Influenza in Adults

Who this might be right for
Healthy Adults
Pfizer 770
Not applicableEnded earlyNCT00170495
What this trial is testing

Acute Viral Respiratory Infections in Elderly

Who this might be right for
Respiratory Infections, Acute
National Institute of Allergy and Infectious Diseases (NIAID) 3,000
Testing effectiveness (Phase 2)Study completedNCT01776541
What this trial is testing

Safety and Immunogenicity of Two Doses of H5N1 Influenza Vaccine in Healthy Adults

Who this might be right for
Pandemic H5N1 Influenza
Novartis Vaccines 979
Not applicableStudy completedNCT04933994
What this trial is testing

Comparison of COVID-19 and H1N1 Influenza Pneumonia

Who this might be right for
COVID-19H1N1 Influenza
Second Affiliated Hospital, Zhejiang University, School of Medicine 483
Large-scale testing (Phase 3)Study completedNCT01954251
What this trial is testing

Study to Evaluate the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Vaccine GSK1437173A When Co-administered With GSK Biologicals' Seasonal Influenza Vaccine GSK2321138A in Adults Aged 50 Years and Older

Who this might be right for
Herpes Zoster
GlaxoSmithKline 829
Large-scale testing (Phase 3)Study completedNCT00192231
What this trial is testing

Trial to Investigate Immune Responses Elicited by a Liquid Formulation of Influenza Virus Vaccine,(CAIV-T)

Who this might be right for
Influenza
MedImmune LLC 120
Early research (Phase 1)Study completedNCT00136331
What this trial is testing

Study of a Pandemic Influenza Vaccine

Who this might be right for
Influenza
Seqirus 400
Post-approval studies (Phase 4)Study completedNCT01047202
What this trial is testing

Sinovac, Pandemic Influenza A/H1N1 Vaccine in 6 to 35 Months Infants

Who this might be right for
Influenza
Sinovac Biotech Co., Ltd 310
Not applicableUnknownNCT01256931
What this trial is testing

Antibody Levels Against 2009 Influenza A H1N1 One Year After Vaccination With Pandemrix and 2010 Fluarix Booster in Organ Transplant Recipients.

Who this might be right for
Organ Transplantation
Sahlgrenska University Hospital 110
Testing effectiveness (Phase 2)Looking for participantsNCT04712539
What this trial is testing

Baloxavir and Oseltamivir for the Treatment of Severe Influenza Infection in Immunocompromised Patients

Who this might be right for
Hematopoietic and Lymphoid Cell NeoplasmInfluenza
M.D. Anderson Cancer Center 60
Large-scale testing (Phase 3)Study completedNCT03391193
What this trial is testing

Immunogenicity and Safety of a Multi-Dose Quadrivalent Influenza Vaccine

Who this might be right for
Influenza
Sanofi Pasteur, a Sanofi Company 301
Post-approval studies (Phase 4)Study completedNCT01000584
What this trial is testing

Rapid Evaluation of Pandemic H1N1 Influenza Vaccine in Adults Receiving Seasonal Influenza Vaccine

Who this might be right for
InfluenzaH1N1 2009 Influenza
David Scheifele 309
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation